These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 30794970)
1. Diagnostic and Prognostic Potential of Serum Cell-Free microRNA-214 in Glioma. Wang J; Che F; Zhang J; Zhang M; Xiao S; Liu Y; Zhou L; Su Q; You C; Lu Y; Heng X World Neurosurg; 2019 May; 125():e1217-e1225. PubMed ID: 30794970 [TBL] [Abstract][Full Text] [Related]
2. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma. Yue X; Lan F; Hu M; Pan Q; Wang Q; Wang J J Neurosurg; 2016 Jan; 124(1):122-8. PubMed ID: 26230475 [TBL] [Abstract][Full Text] [Related]
3. Potential Diagnostic and Prognostic Value of Plasma Circulating MicroRNA-182 in Human Glioma. Xiao Y; Zhang L; Song Z; Guo C; Zhu J; Li Z; Zhu S Med Sci Monit; 2016 Mar; 22():855-62. PubMed ID: 26978735 [TBL] [Abstract][Full Text] [Related]
4. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer. Imaoka H; Toiyama Y; Fujikawa H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Toden S; Goel A; Kusunoki M Ann Oncol; 2016 Oct; 27(10):1879-86. PubMed ID: 27502702 [TBL] [Abstract][Full Text] [Related]
5. A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas. Regazzo G; Terrenato I; Spagnuolo M; Carosi M; Cognetti G; Cicchillitti L; Sperati F; Villani V; Carapella C; Piaggio G; Pelosi A; Rizzo MG J Exp Clin Cancer Res; 2016 Jul; 35(1):124. PubMed ID: 27476114 [TBL] [Abstract][Full Text] [Related]
6. Downregulation of plasma miR-124 expression is a predictive biomarker for prognosis of glioma. Wang LQ; Sun W; Wang Y; Li D; Hu AM Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):271-276. PubMed ID: 30657585 [TBL] [Abstract][Full Text] [Related]
7. Reduced circulating microRNA-203 predicts poor prognosis for glioblastoma. Chen J; Yang L; Wang X Cancer Biomark; 2017 Dec; 20(4):521-526. PubMed ID: 28946553 [TBL] [Abstract][Full Text] [Related]
8. Serum exosomal miR-301a as a potential diagnostic and prognostic biomarker for human glioma. Lan F; Qing Q; Pan Q; Hu M; Yu H; Yue X Cell Oncol (Dordr); 2018 Feb; 41(1):25-33. PubMed ID: 29076027 [TBL] [Abstract][Full Text] [Related]
9. Serum microRNA-376 family as diagnostic and prognostic markers in human gliomas. Huang Q; Wang C; Hou Z; Wang G; Lv J; Wang H; Yang J; Zhang Z; Zhang H Cancer Biomark; 2017; 19(2):137-144. PubMed ID: 28211798 [TBL] [Abstract][Full Text] [Related]
10. High miR-196a and low miR-367 cooperatively correlate with unfavorable prognosis of high-grade glioma. Guan Y; Chen L; Bao Y; Qiu B; Pang C; Cui R; Wang Y Int J Clin Exp Pathol; 2015; 8(6):6576-88. PubMed ID: 26261539 [TBL] [Abstract][Full Text] [Related]
11. Expression and prognostic value of microRNAs in lower-grade glioma depends on IDH1/2 status. Cheng W; Ren X; Zhang C; Han S; Wu A J Neurooncol; 2017 Apr; 132(2):207-218. PubMed ID: 28091987 [TBL] [Abstract][Full Text] [Related]
12. Serum miR-100 is a potential biomarker for detection and outcome prediction of glioblastoma patients. Zhang H; Wang J; Wang Z; Ruan C; Wang L; Guo H Cancer Biomark; 2019; 24(1):43-49. PubMed ID: 30530966 [TBL] [Abstract][Full Text] [Related]
13. A novel serum microRNA-based identification and classification biomarker of human glioma. Xing W; Zeng C Tumour Biol; 2017 May; 39(5):1010428317705339. PubMed ID: 28475008 [TBL] [Abstract][Full Text] [Related]
14. microRNA-328 is a favorable prognostic marker in human glioma via suppressing invasive and proliferative phenotypes of malignant cells. Yuan J; Zheng Z; Zheng Y; Lu X; Xu L; Lin L Int J Neurosci; 2016; 126(2):145-53. PubMed ID: 25562367 [TBL] [Abstract][Full Text] [Related]
15. Downregulation of urinary cell-free microRNA-214 as a diagnostic and prognostic biomarker in bladder cancer. Wang J; Zhang X; Wang L; Dong Z; Du L; Yang Y; Guo Y; Wang C J Surg Oncol; 2015 Jun; 111(8):992-9. PubMed ID: 25975233 [TBL] [Abstract][Full Text] [Related]
16. Predictive and Prognostic Roles of Abnormal Expression of Tissue miR-125b, miR-221, and miR-222 in Glioma. Li X; Zheng J; Chen L; Diao H; Liu Y Mol Neurobiol; 2016 Jan; 53(1):577-583. PubMed ID: 25502291 [TBL] [Abstract][Full Text] [Related]
17. A diagnostic circulating miRNA signature as orchestrator of cell invasion via TKS4/TKS5/EFHD2 modulation in human gliomas. Díaz Méndez AB; Sacconi A; Tremante E; Lulli V; Caprara V; Rosanò L; Goeman F; Carosi M; Di Giuliani M; Vari G; Silvani A; Pollo B; Garufi C; Ramponi S; Simonetti G; Ciusani E; Mandoj C; Scalera S; Villani V; Po A; Ferretti E; Regazzo G; Rizzo MG J Exp Clin Cancer Res; 2023 Mar; 42(1):66. PubMed ID: 36932446 [TBL] [Abstract][Full Text] [Related]
18. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer. Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225 [TBL] [Abstract][Full Text] [Related]
19. Decreased expression of microRNA-107 predicts poorer prognosis in glioma. Ji Y; Wei Y; Wang J; Ao Q; Gong K; Zuo H Tumour Biol; 2015 Jun; 36(6):4461-6. PubMed ID: 25596705 [TBL] [Abstract][Full Text] [Related]
20. Circulating Pre-microRNA-488 in Peripheral Blood Is a Potential Biomarker for Predicting Recurrence in Breast Cancer. Masuda T; Shinden Y; Noda M; Ueo H; Hu Q; Yoshikawa Y; Tsuruda Y; Kuroda Y; Ito S; Eguchi H; Ohno S; Mimori K Anticancer Res; 2018 Aug; 38(8):4515-4523. PubMed ID: 30061217 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]